Atea Pharmaceuticals, Inc. (AVIR) Total liabilities 2021–2022
Atea Pharmaceuticals, Inc. (AVIR) total liabilities at each fiscal year-end, per SEC filings.
$62.8MFY2022 · since FY2021: $315.8M → $62.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $62.8M | -80.1% |
| FY2021 | $315.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice